SAB Biotherapeutics Inc.

NASDAQ: SABS · Real-Time Price · USD
1.83
-0.04 (-2.01%)
At close: Jun 05, 2025, 3:59 PM
1.83
0.27%
After-hours: Jun 05, 2025, 04:00 PM EDT
-2.01%
Bid 1.75
Market Cap 17M
Revenue (ttm) 377.83K
Net Income (ttm) -34.28M
EPS (ttm) -3.8
PE Ratio (ttm) -0.48
Forward PE -1.46
Analyst Buy
Ask 1.99
Volume 2,834
Avg. Volume (20D) 48,728
Open 1.85
Previous Close 1.87
Day's Range 1.79 - 1.85
52-Week Range 1.00 - 5.01
Beta 0.55

About SABS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SABS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SABS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

SAB Biotherapeutics Inc. is scheduled to release its earnings on Jun 17, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+17.06%
SAB Biotherapeutics shares are trading higher afte... Unlock content with Pro Subscription
10 months ago
-12.92%
SAB Biotherapeutics shares are trading lower after the company reported worse-than-expected Q2 EPS results.